You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Aralez Pharmaceuticals, Inc. - VIMOVO Royalties (Divestiture, in 2018)

Transaction #118600
Investor
1
Sign up to view
Target Company
Aralez Pharmaceuticals, Inc. - VIMOVO Royalties
Life Science · Canada
Seller
1
Sign up to view
110 USD
Deal Value
10 Aug 2018
Announced
Target Company
Company Sector Entity Type Status State Country
Aralez Pharmaceuticals, Inc. - VIMOVO Royalties Life Science Private Active Ontario Canada
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Aralez Pharmaceuticals, Inc. - VIMOVO Royalties acquisition deal?
This transaction is an acquisition of Aralez Pharmaceuticals, Inc. - VIMOVO Royalties (Divestiture) in 2018. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Aralez Pharmaceuticals, Inc. - VIMOVO Royalties acquisition happen?
This transaction was announced on 10 Aug 2018.
What is the deal value of the Aralez Pharmaceuticals, Inc. - VIMOVO Royalties acquisition?
The deal value for this transaction is 110 USD.
Who are the investors in the Aralez Pharmaceuticals, Inc. - VIMOVO Royalties transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Aralez Pharmaceuticals, Inc. - VIMOVO Royalties deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial